Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision tag, v3.6.6, appears, replacing the prior v3.6.5, indicating a minor update to the page's versioning.SummaryDifference0.0%

- Check16 days agoChange DetectedTwo NIH grant/contract lines for 2017 and 2023 were added to the study record, reflecting funding support for the LIBRETTO-001 study.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a newer revision of the page content. This change reflects an update to the page's metadata rather than to the study information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page update changes the site revision from v3.6.3 to v3.6.4, indicating a deployment or patch.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page shows a revision label updated to v3.6.3, replacing the previous v3.6.0 to indicate a newer build deployment.SummaryDifference0.0%

- Check87 days agoChange DetectedRecruitment status is updated to not recruiting, reflecting that participants are no longer being sought. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a header formatting change for Intervention/Treatment were added, along with a version update to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.